Brian Lobo, PhDAssociate Director at MedImmune, Inc.
Brian Lobo is an Associate Director in the Dosage Form Design and Development department at MedImmune. He is responsible for early stage formulation development of ADCs, bispecifics, fusion proteins, enzymes and mAbs. Previous to MedImmune, he has worked in formulation development departments at Merck, Amylin and Genentech. His scientific interests are in formulation and characterization of novel protein and peptide modalities and optimization for developability.